The global amiodarone market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of the market can be attributed to factors such as increasing prevalence of cardiac diseases and rising awareness about the benefits of amiodarone in treating cardiac arrhythmias. The global amiodarone market is segmented on the basis of type, application, and region. On the basis of type, it is segmented into tablet, capsule, injection; on the basis of application it is segmented into cardiac arrest, ventricular tachycardia and atrial fibrillation; and on the basis of region it is segmented into North America (US & Canada), Latin America (Mexico & Brazil), Europe (UK & Germany), Asia Pacific (China & India) and Middle East & Africa (Saudi Arabia).
Some Of The Growth Factors Of This Market:
- Amiodarone is a drug that is used to treat and prevent certain types of life-threatening heart rhythm problems, including atrial fibrillation, ventricular tachycardia, and ventricular fibrillation.
- It is also used to prevent recurrent episodes of these types of arrhythmias in people who have survived a previous episode or who have been diagnosed with heart disease.
- Amiodarone has been shown to be effective for the treatment of atrial fibrillation in both the chronic and acute phases as well as for the prevention of recurrence after an initial successful treatment course.
- The drug has also been shown to be effective for the treatment of ventricular tachycardia and ventricular fibrillation.
- Amiodarone can cause serious side effects such as lung damage, liver damage, thyroid problems, skin reactions (including Stevens-Johnson syndrome), eye problems (including cataracts), changes in your menstrual periods (amenorrhea), or sexual difficulties.
Industry Growth Insights published a new data on “Amiodarone Market”. The research report is titled “Amiodarone Market research by Types (Tablet, Capsule, Injection), By Applications (Cardiac Arrest, Ventricular Tachycardia, Atrial Fibrillation, Others), By Players/Companies Sanofi, Sawai Pharmaceutical, Wyeth Pharmaceuticals (Pfizer), Mylan Pharmaceuticals, Arrow Pharma Pty Ltd, Roemmers, Cipla Pharmaceutical, Shanghai Pharmaceuticals, North China Pharmaceutical Company, Harbin Pharmaceutical Group”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Amiodarone Market Research Report
By Type
Tablet, Capsule, Injection
By Application
Cardiac Arrest, Ventricular Tachycardia, Atrial Fibrillation, Others
By Companies
Sanofi, Sawai Pharmaceutical, Wyeth Pharmaceuticals (Pfizer), Mylan Pharmaceuticals, Arrow Pharma Pty Ltd, Roemmers, Cipla Pharmaceutical, Shanghai Pharmaceuticals, North China Pharmaceutical Company, Harbin Pharmaceutical Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Amiodarone Market Report Segments:
The global Amiodarone market is segmented on the basis of:
Types
Tablet, Capsule, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiac Arrest, Ventricular Tachycardia, Atrial Fibrillation, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Sawai Pharmaceutical
- Wyeth Pharmaceuticals (Pfizer)
- Mylan Pharmaceuticals
- Arrow Pharma Pty Ltd
- Roemmers
- Cipla Pharmaceutical
- Shanghai Pharmaceuticals
- North China Pharmaceutical Company
- Harbin Pharmaceutical Group
Highlights of The Amiodarone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Capsule
- Injection
- By Application:
- Cardiac Arrest
- Ventricular Tachycardia
- Atrial Fibrillation
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Amiodarone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Amiodarone is a medication used to treat heart arrhythmias. It works by slowing the heart rate and preventing it from beating too fast.
Some of the major players in the amiodarone market are Sanofi, Sawai Pharmaceutical, Wyeth Pharmaceuticals (Pfizer), Mylan Pharmaceuticals, Arrow Pharma Pty Ltd, Roemmers, Cipla Pharmaceutical, Shanghai Pharmaceuticals, North China Pharmaceutical Company, Harbin Pharmaceutical Group.
The amiodarone market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Amiodarone Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Amiodarone Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Amiodarone Market - Supply Chain
4.5. Global Amiodarone Market Forecast
4.5.1. Amiodarone Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Amiodarone Market Size (000 Units) and Y-o-Y Growth
4.5.3. Amiodarone Market Absolute $ Opportunity
5. Global Amiodarone Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Amiodarone Market Size and Volume Forecast by Type
5.3.1. Tablet
5.3.2. Capsule
5.3.3. Injection
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Amiodarone Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Amiodarone Market Size and Volume Forecast by Application
6.3.1. Cardiac Arrest
6.3.2. Ventricular Tachycardia
6.3.3. Atrial Fibrillation
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Amiodarone Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Amiodarone Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Amiodarone Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Amiodarone Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Amiodarone Demand Share Forecast, 2019-2029
9. North America Amiodarone Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Amiodarone Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Amiodarone Market Size and Volume Forecast by Application
9.4.1. Cardiac Arrest
9.4.2. Ventricular Tachycardia
9.4.3. Atrial Fibrillation
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Amiodarone Market Size and Volume Forecast by Type
9.7.1. Tablet
9.7.2. Capsule
9.7.3. Injection
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Amiodarone Demand Share Forecast, 2019-2029
10. Latin America Amiodarone Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Amiodarone Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Amiodarone Market Size and Volume Forecast by Application
10.4.1. Cardiac Arrest
10.4.2. Ventricular Tachycardia
10.4.3. Atrial Fibrillation
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Amiodarone Market Size and Volume Forecast by Type
10.7.1. Tablet
10.7.2. Capsule
10.7.3. Injection
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Amiodarone Demand Share Forecast, 2019-2029
11. Europe Amiodarone Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Amiodarone Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Amiodarone Market Size and Volume Forecast by Application
11.4.1. Cardiac Arrest
11.4.2. Ventricular Tachycardia
11.4.3. Atrial Fibrillation
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Amiodarone Market Size and Volume Forecast by Type
11.7.1. Tablet
11.7.2. Capsule
11.7.3. Injection
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Amiodarone Demand Share, 2019-2029
12. Asia Pacific Amiodarone Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Amiodarone Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Amiodarone Market Size and Volume Forecast by Application
12.4.1. Cardiac Arrest
12.4.2. Ventricular Tachycardia
12.4.3. Atrial Fibrillation
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Amiodarone Market Size and Volume Forecast by Type
12.7.1. Tablet
12.7.2. Capsule
12.7.3. Injection
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Amiodarone Demand Share, 2019-2029
13. Middle East & Africa Amiodarone Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Amiodarone Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Amiodarone Market Size and Volume Forecast by Application
13.4.1. Cardiac Arrest
13.4.2. Ventricular Tachycardia
13.4.3. Atrial Fibrillation
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Amiodarone Market Size and Volume Forecast by Type
13.7.1. Tablet
13.7.2. Capsule
13.7.3. Injection
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Amiodarone Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Amiodarone Market: Market Share Analysis
14.2. Amiodarone Distributors and Customers
14.3. Amiodarone Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sanofi
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sawai Pharmaceutical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Wyeth Pharmaceuticals (Pfizer)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Mylan Pharmaceuticals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Arrow Pharma Pty Ltd
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Roemmers
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Cipla Pharmaceutical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Shanghai Pharmaceuticals
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. North China Pharmaceutical Company
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Harbin Pharmaceutical Group
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook